malondialdehyde has been researched along with Adult Fanconi Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cetinel, S; Gedik, N; Sakarcan, A; Sehirli, O; Sener, G; Velioğlu-Oğünç, A; Yeğen, BC | 1 |
Altunbaşak, S; Anarat, A; Burgut, HR; Yildizaş, D | 1 |
1 trial(s) available for malondialdehyde and Adult Fanconi Syndrome
Article | Year |
---|---|
Renal tubular dysfunction in epileptic children on valproic acid therapy.
Topics: Acetylglucosamine; Adolescent; Anticonvulsants; beta 2-Microglobulin; Child; Cross-Sectional Studies; Epilepsy; Fanconi Syndrome; Female; Humans; Kidney Function Tests; Kidney Tubules; Longitudinal Studies; Male; Malondialdehyde; Valproic Acid | 2001 |
1 other study(ies) available for malondialdehyde and Adult Fanconi Syndrome
Article | Year |
---|---|
Resveratrol improves ifosfamide-induced Fanconi syndrome in rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Blood Urea Nitrogen; Cytokines; Fanconi Syndrome; Female; Glutathione; Ifosfamide; Kidney; L-Lactate Dehydrogenase; Lipid Peroxidation; Luminescence; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Urinary Bladder | 2007 |